It is worth mentioning that NK cell contribution to tumor eradication may be even more significant than what our data suggest, as NK cell depletion with the commercially available antibody against NKp46 targets only NKp46-domain 1–expressing NK cells, leaving NKp46-domain 2–expressing NK cells intact. Here, NCR1 is linked to neoplasm.